Louis Gaboury

6PUBLICATIONS
13CO-AUTHORS
Solid tumoursPredictive and prognostic markersTumour immunologyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2024
Secretory Carcinoma of the Breast: Radiologic-Pathologic Correlation.

Pamela Boustros, Lilia Maria Sanchez, Louis Gaboury

|Nov 11, 2022
CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.

Lucas Porras, Faustine Gorse, Ndeye Khady Thiombane

|Oct 23, 2021
Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer.

Fatima-Zohra Khadri, Marianne Samir Makboul Issac, Louis Arthur Gaboury

|Aug 19, 2021
Severe Inflammatory Reactions in Mice Expressing a GFI1P2A Mutant Defective in Binding to the Histone Demethylase KDM1A (LSD1).

Jennifer Fraszczak, Kaifee Mohammad Arman, Marion Lacroix

|Jan 27, 2021
Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.

Camille Gauvin, Vimal Krishnan, Imane Kaci

|Jul 22, 2020
IFN-λ Enhances Constitutive Expression of MHC Class I Molecules on Thymic Epithelial Cells.

Mohamed Benhammadi, Justine Mathé, Maude Dumont-Lagacé

Pageof 1